Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment
Authors:
Top Cited Papers
Open Access
- 6 June 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1597559
Abstract
Objective: ADHD, or Attention-Deficit/Hyperactivity Disorder, is a neurodevelopmental disorder that is known for its high degree of heterogeneity. It often coexists with other psychiatric diseases, especially anxiety and depression. This article reviews recent studies to explore the etiology of comorbid anxiety and depressive disorders in adults with ADHD, analyzing the factors contributing to this elevated comorbidity rate from several perspectives. Additionally, we explore potential directions for future research in this field.Recent findings: ADHD exhibits a high comorbidity rate with anxiety and depressive disorders, due to overlapping and interacting symptoms. Individuals with two or more comorbid conditions often experience increased disease burden, prolonged illness duration, and diminished treatment efficacy. The underlying causes of comorbid anxiety and depression in ADHD patients are highly complex and can be understood from multiple dimensions, including genetics, neurobiology, neurocognition, and neuroimaging. This complexity poses significant challenges for clinical diagnosis and treatment. Currently, the management of ADHD patients with concurrent depression or anxiety may involve pharmaceutical interventions combined with non-pharmacological strategies, including psychotherapy (e.g., cognitive-behavioral therapy, CBT) and digital therapeutics. For patients with comorbid illnesses, these intergrated approaches have demonstrated significant improvements in symptom relief and quality of life enhancement.Summary: ADHD is a highly heterogeneous disorder with a significant comorbidity rate. Recent research has elucidated the pathogenetic mechanisms of ADHD comorbid with depression and anxiety disorders from multiple perspectives. To improve patient functioning, enhance their quality of life, and guide more effective treatments, Further studies are needed to investigate the underlying causes of these comorbid conditions.Keywords
This publication has 95 references indexed in Scilit:
- Combined Methylphenidate and Selective Serotonin Reuptake Inhibitors in Adults With Attention-Deficit/Hyperactivity DisorderJAMA Network Open, 2024
- Characterizing Developmental Trajectories and the Role of Neuropsychiatric Genetic Risk Variants in Early-Onset DepressionJAMA Psychiatry, 2019
- The relationships between rumination and core executive functions: A meta-analysisDepression and Anxiety, 2016
- Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young AdulthoodJAMA Psychiatry, 2016
- Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young AdulthoodJAMA Psychiatry, 2016
- ANXIOUS AND AGGRESSIVE: THE CO-OCCURRENCE OF IED WITH ANXIETY DISORDERSDepression and Anxiety, 2015
- On the role ofNOS1ex1f‐VNTR in ADHD—allelic, subgroup, and meta‐analysisAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2015
- Large-Scale Network Dysfunction in Major Depressive DisorderJAMA Psychiatry, 2015
- NCAM1‐TTC12‐ANKK1‐DRD2 gene cluster and the clinical and genetic heterogeneity of adults with ADHDAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2015
- Architectonic subdivision of the human orbital and medial prefrontal cortexJournal of Comparative Neurology, 2003